Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444392 · ClinicalTrials.gov registry record · Phase 3
Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus
A Phase 3 study of Type 2 Diabetes Mellitus and Obese Patients, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 3
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT00444392: Completed Phase 3 study of Type 2 Diabetes Mellitus and Obese Patients, sponsored by Vanderbilt University.
NCT00444392 is a Phase 3 study of Type 2 Diabetes Mellitus and Obese Patients that has completed, run by Vanderbilt University. The registered enrollment target is 9 participants, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00444392, a Phase 3 study of Type 2 Diabetes Mellitus and Obese Patients, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
Central hypothesis is: Gastric bypass surgery reduces the risk of CVD in morbidly obese subjects (defined as BMI ≥35 kg/m2) with T2DM. To determine whether surgically induced weight loss decreases the risk of CVD in morbidly obese subjects with T2DM. I hypothesize that patients with T2DM who undergo gastric bypass surgery will significantly reduce mean levels of risk factors for CVD compared with diabetic individuals with the same BMI who maintain their weight.
Conditions Studied
Interventions
- BEHAVIORAL Calorie controlled diabetic diet for the control patients
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-03 |
| Phase | Phase 3 |
What the finished NCT00444392 record still lists
NCT00444392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Calorie controlled diabetic diet for the control patients is the first listed.
NCT00444392 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00444392 about?
NCT00444392 is a clinical study titled "Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus". Central hypothesis is: Gastric bypass surgery reduces the risk of CVD in morbidly obese subjects (defined as BMI ≥35 kg/m2) with T2DM. To determine whether surgically induced weight loss decreases the risk of CVD in morbidly obese subjects with T2DM. I hypothesize that patients with T2DM who underg...
What is the current status of trial NCT00444392?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 9 participants. The study started on 2007-03. Estimated completion is 2009-03.
What conditions does trial NCT00444392 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Obese Patients.
What interventions are being tested in trial NCT00444392?
The interventions under investigation include: Calorie controlled diabetic diet for the control patients (BEHAVIORAL).
Who is sponsoring clinical trial NCT00444392?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00444392 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00444392's enrollment target sits among peer trials
9 128th of 130 higher than 3 of 130 other Type 2 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes
RECRUITING · Phase 3
-
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
RECRUITING · Phase 3
-
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
COMPLETED · Phase 3
-
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
COMPLETED · Phase 3
-
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
COMPLETED · Phase 3
-
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia